Will real-world evidence make an impact in 2014?

Collecting real-world data will present a huge challenge for pharmaceutical companies developing a new medicine, so they need to start planning for it early in development says Dr Thomas Lönngren, strategic adivsor, NDA Group in the latest issue of Pharma Times.

Full article:  Vision 2014

Dr Thomas Lönngren

 

 

 

 

 

Dr. Thomas Lönngren
Strategic advisor, NDA Group